<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Res</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Res</journal-id><journal-id journal-id-type="publisher-id">JDR</journal-id><journal-title-group><journal-title>Journal of Diabetes Research</journal-title></journal-title-group><issn pub-type="ppub">2314-6745</issn><issn pub-type="epub">2314-6753</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4769769</article-id><article-id pub-id-type="doi">10.1155/2016/6179635</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Sulfatide Preserves Insulin Crystals Not by Being Integrated in the Lattice but by Stabilizing Their Surface </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Buschard</surname><given-names>Karsten</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bracey</surname><given-names>Austin W.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>McElroy</surname><given-names>Daniel L.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Magis</surname><given-names>Andrew T.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Osterbye</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Atkinson</surname><given-names>Mark A.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bailey</surname><given-names>Kate M.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Posgai</surname><given-names>Amanda L.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ostrov</surname><given-names>David A.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Bartholin Instituttet, Rigshospitalet, 2100 Copenhagen, Denmark</aff><aff id="I2"><sup>2</sup>Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, 1600 SW Archer Road, Gainesville, FL 32610, USA</aff><author-notes><corresp id="cor1">*Karsten Buschard: <email>buschard@dadlnet.dk</email></corresp><fn fn-type="other"><p><text><SENT sid="1" pm="."><plain>Academic Editor: Fabrizio Barbetti </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>14</day><month>2</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>6179635</elocation-id><history><date date-type="received"><day>30</day><month>10</month><year>2015</year></date><date date-type="rev-recd"><day>14</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>Copyright © 2016 Karsten Buschard et al.</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Background. </plain></SENT>
<SENT sid="3" pm="."><plain>Sulfatide is known to chaperone insulin crystallization within the pancreatic beta cell, but it is not known if this results from sulfatide being integrated inside the crystal structure or by binding the surface of the crystal. </plain></SENT>
<SENT sid="4" pm="."><plain>With this study, we aimed to characterize the molecular mechanisms underlying the integral role for sulfatide in stabilizing insulin crystals prior to exocytosis. Methods. </plain></SENT>
<SENT sid="5" pm="."><plain>We cocrystallized human insulin in the presence of sulfatide and solved the structure by molecular replacement. Results. </plain></SENT>
<SENT sid="6" pm="."><plain>The crystal structure of insulin crystallized in the presence of sulfatide does not reveal ordered occupancy representing sulfatide in the crystal lattice, suggesting that sulfatide does not permeate the crystal lattice but exerts its stabilizing effect by alternative interactions such as on the external surface of insulin crystals. Conclusions. </plain></SENT>
<SENT sid="7" pm="."><plain>Sulfatide is known to stabilize insulin crystals, and we demonstrate here that in beta cells sulfatide is likely coating insulin crystals. </plain></SENT>
<SENT sid="8" pm="."><plain>However, there is no evidence for sulfatide to be built into the crystal lattice. </plain></SENT>
</text></SecTag></p></abstract></article-meta></front><body><SecTag type="INTRO"><sec id="sec1"><title><text><SENT sid="9" pm="."><plain>1. </plain></SENT>
<SENT sid="10" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="11" pm="."><plain>In beta cells of the islets of Langerhans, insulin is stored in granules as part of a crystalline insulin structure [1]. </plain></SENT>
<SENT sid="12" pm="."><plain>These molecular entities are formed within the Golgi apparatus known to contain zinc (Zn) molecules [1, 2]. </plain></SENT>
<SENT sid="13" pm="."><plain>Upon exocytosis into the bloodstream, the insulin crystals revert to a hexameric entity and subsequently transition into a monomeric biologically active form [3, 4]. </plain></SENT>
<SENT sid="14" pm="."><plain>It has been demonstrated that the glycosphingolipid, sulfated beta-galactosylceramide, also denominated sulfatide, acts as a chaperone for insulin during its folding prior to resolution into insulin crystals [5] and that sulfatide preserves these insulin crystals [5]. </plain></SENT>
<SENT sid="15" pm="."><plain>Within beta cells, sulfatide is present within the Golgi and insulin granules, as well as at the membrane surface [6]. </plain></SENT>
</text></p><p><text><SENT sid="16" pm="."><plain>The purpose of this current study was to characterize the relationship between insulin and sulfatide in order to gain additional understanding as to the importance of this association with metabolism and, potentially, aberrations related to this process that might influence health (i.e., diabetes, insulin resistance). </plain></SENT>
<SENT sid="17" pm="."><plain>The main question to be answered in this study is whether sulfatide is built into the crystals or is managing its preservation effect just by being attached to the surface of the insulin crystal. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec2"><title><text><SENT sid="18" pm="."><plain>2. </plain></SENT>
<SENT sid="19" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec id="sec2.1"><title><text><SENT sid="20" pm="."><plain>2.1. </plain></SENT>
<SENT sid="21" pm="."><plain>Purification of Insulin </plain></SENT>
</text></title><p><text><SENT sid="22" pm="."><plain>The human insulin gene (Novo Nordisk, Bagsvaerd, Denmark) was cloned into the pAK721 vector for expression in Saccharomyces cerevisiae. </plain></SENT>
<SENT sid="23" pm="."><plain>The native C-peptide was replaced by a synthetic minipeptide AAK, connecting the A- and B-chains, and pure insulin was obtained as earlier described [7]. </plain></SENT>
</text></p></sec><sec id="sec2.2"><title><text><SENT sid="24" pm="."><plain>2.2. </plain></SENT>
<SENT sid="25" pm="."><plain>Cocrystallization of Insulin-Sulfatide Complexes </plain></SENT>
</text></title><p><text><SENT sid="26" pm="."><plain>Insulin and sulfatide (Avanti Polar Lipids, Inc., Alabaster, AL, USA) were mixed in a 1 : 3 molar ratio, and crystals were grown using the hanging drop vapor diffusion method [7, 8]. </plain></SENT>
<SENT sid="27" pm="."><plain>Preliminary screens were performed using sparse-matrix crystallization to determine initial conditions [9]. </plain></SENT>
<SENT sid="28" pm="."><plain>Crystals were grown in conditions that contain zinc acetate or magnesium sulfate as in previous studies [5]. </plain></SENT>
<SENT sid="29" pm="."><plain>Conditions were optimized based on the crystals grown in 1.6 mol/L magnesium sulfate and 0.1 mol/L MES pH 6.5. </plain></SENT>
<SENT sid="30" pm="."><plain>Large crystals (up to 200 μm in the longest dimension) were obtained in five days in 1.3 mol/L magnesium sulfate and 0.1 mol/L MES pH 7.5. </plain></SENT>
<SENT sid="31" pm="."><plain>The single crystal used for the data reported was grown in a hanging drop containing 2 μL protein solution (10 mg/mL + 10.3 mmol/L sulfatide) and 3 μL reservoir solution. </plain></SENT>
<SENT sid="32" pm="."><plain>All crystallization trials were performed at 22°C. </plain></SENT>
</text></p></sec><sec id="sec2.3"><title><text><SENT sid="33" pm="."><plain>2.3. </plain></SENT>
<SENT sid="34" pm="."><plain>X-Ray Data Collection </plain></SENT>
</text></title><p><text><SENT sid="35" pm="."><plain>Data was collected on beamline X6A at the National Synchrotron Light Source (Brookhaven National Laboratories, Upton, NY, USA). </plain></SENT>
<SENT sid="36" pm="."><plain>Images were collected using an ADSC 210 CCD detector and indexed and scaled using HKL2000 [10]. </plain></SENT>
<SENT sid="37" pm="."><plain>XPREP [11] was used to assist space group determination. </plain></SENT>
<SENT sid="38" pm="."><plain>The selected insulin/sulfatide crystal was cryoprotected using paraffin oil, cooled in a stream of gaseous nitrogen. </plain></SENT>
<SENT sid="39" pm="."><plain>The crystal was mounted at a distance of 120 mm from the detector and at an X-ray wavelength of 0.9322 Å. 300 frames were collected, 8 seconds per image, with 0.5° oscillation steps for each frame. </plain></SENT>
<SENT sid="41" pm="."><plain>The molecular replacement software PHASER-MR implemented in PHENIX was used for phasing. </plain></SENT>
<SENT sid="42" pm="."><plain>PHENIX.REFINE: 1.9_1692 was used for refinement. </plain></SENT>
<SENT sid="43" pm="."><plain>PDB code 2INS [12] was the initial model used for phasing. </plain></SENT>
<SENT sid="44" pm="."><plain>Difference electron density maps were created comparing electron density of the crystal versus electron density explained by the model. </plain></SENT>
</text></p></sec><sec id="sec2.4"><title><text><SENT sid="45" pm="."><plain>2.4. </plain></SENT>
<SENT sid="46" pm="."><plain>Electron Microscopy </plain></SENT>
</text></title><p><text><SENT sid="47" pm="."><plain>Islet tissue was obtained from 9-week-old male Lewis rats purchased from Taconic Biosciences, Inc. </plain></SENT>
<SENT sid="48" pm="."><plain>(Hudson, NY, USA). </plain></SENT>
<SENT sid="49" pm="."><plain>The islets were isolated using a collagenase method [13]. </plain></SENT>
<SENT sid="50" pm="."><plain>Isolated islets were incubated overnight at 4°C with the sulfatide-specific monoclonal antibody, Sulph I (gift from Pam Fredman), diluted as 1 : 1000 [14], and after washing in 1% PBS-BSA, the islets were incubated overnight at 4°C with 1 nm gold labeled goat anti-mouse IgG (BBI Solutions, Cardiff, UK) diluted as 1 : 300 in 1% PBS-BSA and absorbed with rat serum. </plain></SENT>
<SENT sid="51" pm="."><plain>The islets were postfixed after washing in 2% glutaraldehyde for 2 h and washed in distilled water, before silver enhancement using AURION R-GENT SE-EM (Aurion, Wageningen, NL). </plain></SENT>
<SENT sid="52" pm="."><plain>The islets were washed in distilled water before osmication in 1% OsO4 diluted in 0.1 M cacodylate buffer. </plain></SENT>
<SENT sid="53" pm="."><plain>After washing in 0.1 M cacodylate buffer, the specimens were dehydrated in alcohol and embedded in Epon Resin 812 before ultra-sections were examined in a Philips 208 electron microscope. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="sec3"><title><text><SENT sid="54" pm="."><plain>3. </plain></SENT>
<SENT sid="55" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="56" pm="."><plain>Staining of beta cells for sulfatide demonstrated a close relationship to the insulin crystals even at exocytosis (Figure 1(a)). </plain></SENT>
<SENT sid="57" pm="."><plain>As sulfatide has previously been noted to promote stability of insulin crystals within pancreatic beta cells [5], we investigated the molecular mechanisms supporting an integral role for sulfatide in insulin crystal formation and preservation. </plain></SENT>
<SENT sid="58" pm="."><plain>We cocrystallized human insulin with sulfatide in the presence of Zn (Figure 1(b)) and observed that crystals containing insulin bound to sulfatide appeared in a rhombohedral lattice, the same space group that has been reported for insulin molecules found in pancreatic tissue [15, 16]. </plain></SENT>
<SENT sid="59" pm="."><plain>The crystals were completely translucent to visible light and did not display precipitation either on the surface or within. </plain></SENT>
<SENT sid="60" pm="."><plain>X-ray diffraction data was collected to 1.6 Å resolution and reduced to a primitive rhombohedral lattice, H3 (Table 1). </plain></SENT>
<SENT sid="61" pm="."><plain>The unit cell parameters were a = b = 81.61 Å, c = 33.729 Å, with α = β = 90.0°, γ = 120.0°. </plain></SENT>
<SENT sid="62" pm="."><plain>Matthew's coefficient of 1.88 Å3 Da−1 is consistent with the presence of one insulin molecule per asymmetric unit [17]. </plain></SENT>
</text></p><p><text><SENT sid="63" pm="."><plain>The structure was solved by molecular replacement [12] and refined yielding statistics shown in Table 1, deposited in the Protein Data Bank as code 4XC4. </plain></SENT>
<SENT sid="64" pm="."><plain>Difference electron density maps revealed ordered water molecules and Zn in positions consistent with other hexameric insulin structures (Figures 1(c) and 1(d)) [5, 16]. </plain></SENT>
<SENT sid="65" pm="."><plain>Ordered electron density consistent with sulfatide was not observed. </plain></SENT>
<SENT sid="66" pm="."><plain>These data suggest that sulfatide does not stabilize insulin crystals through a mechanism involving stable contacts with insulin residues. </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec id="sec4"><title><text><SENT sid="67" pm="."><plain>4. </plain></SENT>
<SENT sid="68" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="69" pm="."><plain>In this study we have shown that sulfatide is closely related to and covers the insulin crystals in vivo. </plain></SENT>
<SENT sid="70" pm="."><plain>Furthermore, sulfatide is known to preserve insulin crystals in spite of our present findings that sulfatide is not integrated inside the matrix. </plain></SENT>
</text></p><p><text><SENT sid="71" pm="."><plain>Beta cells must store large quantities of insulin within the secretory granules in preparation for normal blood glucose regulation. </plain></SENT>
<SENT sid="72" pm="."><plain>However, insulin has a tendency to fibrillate which renders it biologically inactive. </plain></SENT>
<SENT sid="73" pm="."><plain>For having enough storage, nature has solved this problem by crystallization of insulin that cannot fibrillate. </plain></SENT>
<SENT sid="74" pm="."><plain>Insulin is present in beta cells as hexamers that build into crystals that must be stable for weeks but simultaneously capable of being secreted immediately on demand of the blood glucose values. </plain></SENT>
<SENT sid="75" pm="."><plain>Thus, the insulin crystals should be able to break down very quickly, dissociating into monomers capable of binding the insulin receptor. </plain></SENT>
</text></p><p><text><SENT sid="76" pm="."><plain>It has been previously demonstrated that at low pH (5.5) with high concentration of Zn++ insulin crystals are well preserved in presence of sulfatide [5]. </plain></SENT>
<SENT sid="77" pm="."><plain>At exocytosis of the insulin granules and thereby insulin secretion, the pH increases to 7.4 and the Zn++ concentration is lowered, potentiating monomerization. </plain></SENT>
<SENT sid="78" pm="."><plain>We hypothesized that sulfatide may act as a chaperone for insulin and preserve its crystals within the beta cell granule due to integration of the glycolipid into the insulin crystal. </plain></SENT>
<SENT sid="79" pm="."><plain>The present study suggests that sulfatide is coating the outside of the insulin crystals (as opposed to binding within the insulin crystal lattice), which is consistent with data showing close associations in vivo. </plain></SENT>
<SENT sid="80" pm="."><plain>The blood concentration of sulfatide has been noted to be lower in patients with type 2 diabetes [18], so sulfatide might offer a level of protection or improvement in insulin physiology. </plain></SENT>
<SENT sid="81" pm="."><plain>Further, sulfatide has been noted to be present at reduced quantities within the secretory granules of stressed beta cells [19]. </plain></SENT>
<SENT sid="82" pm="."><plain>Autoantibodies against sulfatide have been documented in patients with type 1 diabetes [20]. </plain></SENT>
<SENT sid="83" pm="."><plain>As being present at the surface of the insulin crystals only, variations in the amount of sulfatide might be critical for the beta cells. </plain></SENT>
<SENT sid="84" pm="."><plain>Thus, interactions between sulfatide and insulin crystals may have implications on disease pathogenesis in both type 1 and type 2 diabetes, which must be subject to further investigation. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgments</title><p><text4fund><text><SENT sid="85" pm="."><plain>The authors thank Susanne Sørensen for excellent performance of the electron microscopy. </plain></SENT>
<SENT sid="86" pm="."><plain>This work was funded by Brehm Coalition for Type 1 Diabetes Research. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="COMP_INT"><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare no conflict of interests.</p></sec></SecTag><SecTag type="AUTH_CONT"><sec><title>Authors' Contribution</title><p>Karsten Buschard conceived the study and wrote the paper, Austin W. Bracey and Daniel L. McElroy researched the data and edited the paper, Andrew T. Magis researched the data and wrote the paper, Thomas Osterbye researched the data and reviewed/edited the paper, Mark A. Atkinson contributed to discussion and reviewed/edited the paper, Kate M. Bailey researched the data and reviewed/edited the paper, Amanda L. Posgai contributed to discussion and wrote the paper, and David A. Ostrov conceived of the study and wrote the paper.</p></sec></SecTag><SecTag type="REF"><ref-list><ref id="B1"><text><SENT sid="87" pm="."><plain>1PittmanI.PhilipsonL.SteinerD.Insulin biosynthesis, secretion, structure, and structure-activity relationships2004, <ext-link ext-link-type="uri" xlink:href="http://diabetesmanager.pbworks.com/w/page/17680216/InsulinBiosynthesis,Secretion,Structure,andStructure-ActivityRelationships">http://diabetesmanager.pbworks.com/w/page/17680216/Insulin Biosynthesis, Secretion, Structure, and Structure-Activity Relationships</ext-link> </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="88" pm="."><plain>2EideD. </plain></SENT>
<SENT sid="89" pm="."><plain>J.Zinc transporters and the cellular trafficking of zincBiochimica et Biophysica Acta—Molecular Cell Research20061763771172210.1016/j.bbamcr.2006.03.0052-s2.0-33746929895 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="90" pm="."><plain>3OrciL.The insulin cell: Its cellular environment and how it processes (Pro)insulinDiabetes/Metabolism Reviews198621-27110610.1002/dmr.56100201062-s2.0-00225290193013544 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="91" pm="."><plain>4DodsonG.SteinerD.The role of assembly in insulin's biosynthesisCurrent Opinion in Structural Biology19988218919410.1016/S0959-440X(98)80037-72-s2.0-00320547149631292 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="92" pm="."><plain>5OsterbyeT.JørgensenK. </plain></SENT>
<SENT sid="93" pm="."><plain>H.FredmanP.Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerizationGlycobiology200111647347910.1093/glycob/11.6.4732-s2.0-003493911611445552 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="94" pm="."><plain>6FredmanP.MånssonJ.-E.RynmarkB.-M.The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin traffickingGlycobiology2000101395010.1093/glycob/10.1.392-s2.0-034355032910570222 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="95" pm="."><plain>7KjeldsenT.Yeast secretory expression of insulin precursorsApplied Microbiology and Biotechnology200054327728610.1007/s0025300004022-s2.0-003380717711030562 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="96" pm="."><plain>8McPhersonA.Crystallization of Biological Macromolecules1999New York, NY, USACold Spring Harbor Laboratory Press </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="97" pm="."><plain>9JancarikJ.KimS.-H.Sparse matrix sampling: a screening method for crystallization of proteinsJournal of Applied Crystallography199124440941110.1107/s00218898910044302-s2.0-0026206788 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="98" pm="."><plain>10OtwinowskiZ.MinorW.CarterC. </plain></SENT>
<SENT sid="99" pm="."><plain>W.Jr.SweetR. </plain></SENT>
<SENT sid="100" pm="."><plain>M.Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology1997New York, NY, USAAcademic Press307326 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="101" pm="."><plain>11SheldrickG.XPREP. </plain></SENT>
<SENT sid="102" pm="."><plain>Space Group Determination and Reciprocal Space Plots1991Siemens Analytical X-Ray Instruments </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="103" pm="."><plain>12WlodawerA.SavageH.DodsonG.Structure of insulin: results of joint neutron and X-ray refinementActa Crystallographica Section B1989459910710.1107/s01087681880110122-s2.0-0024610022 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="104" pm="."><plain>13BuschardK.AaenK.HornT.Van DammeJ.BendtzenK.Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of langerhansAutoimmunity19905318519410.3109/089169390090029772-s2.0-00251306652129751 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="105" pm="."><plain>14FredmanP.MattssonL.AnderssonK.Characterization of the binding epitope of a monoclonal antibody to sulphatideBiochemical Journal19882511172210.1042/bj25100172-s2.0-00238915952455508 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="106" pm="."><plain>15ScottD. </plain></SENT>
<SENT sid="107" pm="."><plain>A.Crystalline insulinBiochemical Journal19342841592160210.1042/bj028159216745551 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="108" pm="."><plain>16BlundellT.DodsonG.HodgkinD.MercolaD.Insulin: the structure in the crystal and its reflection in chemistry and biologyAdvances in Protein Chemistry197226Philadelphia, Pa, USAElsevier27940210.1016/S0065-3233(08)60143-6 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="109" pm="."><plain>17KantardjieffK. </plain></SENT>
<SENT sid="110" pm="."><plain>A.RuppB.Matthews coefficient probabilities: improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystalsProtein Science20031291865187110.1110/ps.03505032-s2.0-004201122412930986 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="111" pm="."><plain>18BuschardK.FredmanP.Bøg-HansenE.Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. </plain></SENT>
<SENT sid="112" pm="."><plain>The Skaraborg ProjectDiabetic Medicine20052291190119810.1111/j.1464-5491.2005.01613.x2-s2.0-2404450440716108848 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="113" pm="."><plain>19BuschardK.SchlootN. </plain></SENT>
<SENT sid="114" pm="."><plain>C.KaasA.Inhibition of insulin-specific autoreactive T-cells by sulphatide which is variably expressed in beta cellsDiabetologia199942101212121810.1007/s0012500512942-s2.0-003284342810525662 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="115" pm="."><plain>20AnderssonK.BuschardK.FredmanP.Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assayAutoimmunity200235746346810.1080/08916930210000473612-s2.0-1224425079412685874 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="116" pm="."><plain>(a) Electron microscopy of a beta cell stained for sulfatide with colloidal gold granules as secondary indications. </plain></SENT>
<SENT sid="117" pm="."><plain>Close relationship to the insulin crystals is clearly seen. </plain></SENT>
<SENT sid="118" pm="."><plain>At the surface at the beta cells an insulin crystal close to exocytosis is clearly seen at one quartile from the right in the horizontal axis and half down in the vertical axis. </plain></SENT>
<SENT sid="119" pm="."><plain>(b) Upon crystallization, insulin formed hexamers of approximately 100 μm diameter. </plain></SENT>
<SENT sid="120" pm="."><plain>((c) and (d)) Structure of insulin crystallized in the presence of sulfatide shows classic features of zinc bound insulin hexamers. </plain></SENT>
<SENT sid="121" pm="."><plain>(c) The crystals structure of insulin (PDB code 4XC4). </plain></SENT>
<SENT sid="122" pm="."><plain>Zinc is depicted as gray spheres. </plain></SENT>
<SENT sid="123" pm="."><plain>(d) An electron density map surrounding the disulfide bond linking cysteine chain A 20 to cysteine chain B 19. </plain></SENT>
</text></p></caption><graphic xlink:href="JDR2016-6179635.001"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p><text><SENT sid="124" pm="."><plain>X-ray diffraction data for insulin crystalized in the presence of sulfatide. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="2" rowspan="1"><text><SENT sid="125" pm="."><plain>PDB 4XC4 </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>Resolution range (Å) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>30–1.5 (1.553–1.499) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>Space group </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>R3:H </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>Unit cell </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>a = 81.61,  b = 81.61, and  c = 33.73; α = 90,  β = 90, and  γ = 120 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>Total reflections (unique) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>11,654 (1,124) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>Completeness (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>86.62 (82.71) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>Mean I/sigma(I) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>18.52 (2.60) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>Wilson B-factor </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>20.27 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>R-work </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>0.2180 (0.3020) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>R-free </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>0.2540 (0.3595) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>Number of nonhydrogen atoms </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>870 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>Macromolecules </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>865 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>Residues </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>101 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>RMS (bonds) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>0.008 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>RMS (angles) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>1.06 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>Ramachandran favored (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>95 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>Ramachandran allowed (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>4.01 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>Ramachandran outliers (%) </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>0.99 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>B-factor </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>29.00 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>Macromolecules </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>29.00 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>Ligands </plain></SENT>
</text></td><td align="center" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>33.50 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></floats-group></article>
